SE437219B - PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT - Google Patents

PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT

Info

Publication number
SE437219B
SE437219B SE7600284A SE7600284A SE437219B SE 437219 B SE437219 B SE 437219B SE 7600284 A SE7600284 A SE 7600284A SE 7600284 A SE7600284 A SE 7600284A SE 437219 B SE437219 B SE 437219B
Authority
SE
Sweden
Prior art keywords
protrahered
preparing
procedure
effect
insulin preparation
Prior art date
Application number
SE7600284A
Other languages
Swedish (sv)
Other versions
SE7600284L (en
Inventor
B A Hansen
F H Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of SE7600284L publication Critical patent/SE7600284L/en
Publication of SE437219B publication Critical patent/SE437219B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7600284A 1975-01-15 1976-01-13 PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT SE437219B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (en) 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation.

Publications (2)

Publication Number Publication Date
SE7600284L SE7600284L (en) 1976-07-16
SE437219B true SE437219B (en) 1985-02-18

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600284A SE437219B (en) 1975-01-15 1976-01-13 PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT

Country Status (36)

Country Link
JP (1) JPS5946939B2 (en)
AR (1) AR213088A1 (en)
AT (1) AT362492B (en)
BE (1) BE837600A (en)
BR (1) BR7600206A (en)
CA (1) CA1094549A (en)
CH (1) CH631625A5 (en)
CS (1) CS208147B2 (en)
DD (1) DD124379A5 (en)
DE (1) DE2600971C2 (en)
DK (1) DK140801B (en)
EG (1) EG11988A (en)
ES (1) ES444558A1 (en)
FI (1) FI66751C (en)
FR (1) FR2297634A1 (en)
GB (1) GB1524431A (en)
GR (1) GR58608B (en)
HU (1) HU175142B (en)
IE (1) IE42395B1 (en)
IL (1) IL48845A (en)
IN (1) IN143279B (en)
IT (1) IT1054211B (en)
KE (1) KE2919A (en)
LU (1) LU74175A1 (en)
MX (1) MX4052E (en)
MY (1) MY7900169A (en)
NL (1) NL166464C (en)
NO (1) NO146698C (en)
NZ (1) NZ179733A (en)
OA (1) OA05209A (en)
PL (1) PL99927B1 (en)
PT (1) PT64696B (en)
RO (1) RO71576A (en)
SE (1) SE437219B (en)
YU (1) YU8376A (en)
ZA (1) ZA7658B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (en) * 1979-09-07 1981-03-08 Nordisk Insulinlab PROCEDURE FOR THE PREPARATION OF AN INJUCABLE INSULIN PREPARATION
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (en) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Method for coating a surface of a component
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
LT3928818T (en) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Nebulizer and container
JP6580070B2 (en) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Container, nebulizer, and use
PL3139984T3 (en) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
DK8375A (en) 1976-07-16
BR7600206A (en) 1976-08-31
NL166464B (en) 1981-03-16
ZA7658B (en) 1976-12-29
NZ179733A (en) 1978-04-28
AT362492B (en) 1981-05-25
EG11988A (en) 1978-06-30
MY7900169A (en) 1979-12-31
DE2600971A1 (en) 1976-07-22
FI66751C (en) 1984-12-10
BE837600A (en) 1976-07-15
LU74175A1 (en) 1977-03-18
DE2600971C2 (en) 1985-12-12
FI760058A (en) 1976-07-16
IL48845A0 (en) 1976-03-31
PL99927B1 (en) 1978-08-31
ATA21376A (en) 1980-10-15
CA1094549A (en) 1981-01-27
CH631625A5 (en) 1982-08-31
RO71576A (en) 1980-12-30
FR2297634B1 (en) 1979-03-30
MX4052E (en) 1981-11-24
CS208147B2 (en) 1981-08-31
HU175142B (en) 1980-05-28
GB1524431A (en) 1978-09-13
DK140801B (en) 1979-11-19
AU1030776A (en) 1977-07-21
JPS51125299A (en) 1976-11-01
JPS5946939B2 (en) 1984-11-15
NL7600338A (en) 1976-07-19
NO760118L (en) 1976-07-16
DD124379A5 (en) 1977-02-16
PT64696B (en) 1977-08-10
ES444558A1 (en) 1977-05-16
NO146698C (en) 1982-11-24
NL166464C (en) 1981-08-17
SE7600284L (en) 1976-07-16
YU8376A (en) 1982-06-30
GR58608B (en) 1977-11-10
DK140801C (en) 1980-04-21
IT1054211B (en) 1981-11-10
IL48845A (en) 1981-06-29
PT64696A (en) 1976-02-01
IE42395L (en) 1976-07-15
AR213088A1 (en) 1978-12-15
IN143279B (en) 1977-10-29
FR2297634A1 (en) 1976-08-13
NO146698B (en) 1982-08-16
FI66751B (en) 1984-08-31
OA05209A (en) 1981-02-28
KE2919A (en) 1979-03-30
IE42395B1 (en) 1980-07-30

Similar Documents

Publication Publication Date Title
SE437219B (en) PROCEDURE FOR PREPARING A STABLE INSULIN PREPARATION WITH PROTRAHERED EFFECT
SE434395B (en) ANALOGY PROCEDURE FOR PREPARING CARBOSTYRIC DERIVATIVES WITH THERAPEUTIC EFFECT
SE433804B (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PHARMACEUTICAL PREPARATION
SE448790B (en) PROCEDURE FOR PREPARING A DOCUMENT
SE420921B (en) ANALOGY PROCEDURE FOR PREPARING CHINAZOLINE DERIVATIVES WITH THERAPEUTICAL EFFECT
SE435569B (en) PROCEDURE FOR PREPARING A MEDICAL TABLE WITH REGULATED RELEASE
NO146044C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL INSULIN PREPARATION FOR RECTAL USE
SE7607565L (en) PROCEDURE FOR PREPARING AN ANTIDEPRESSIVE
SE426780B (en) PROCEDURE FOR PREPARING A CEPHALEXIN PREPARATION
SE433745B (en) PROCEDURE FOR PREPARING TETRAHYDROISOKINOLIN DERIVATIVES
SE401182B (en) FURANHYDROXAMIC ACID DERIVATIVES WITH FUNGICIDAL EFFECT
SE432250B (en) PROCEDURE FOR PREPARING A CHINAZOLINE DERIVATIVE
SE423390B (en) PROCEDURES FOR PREPARING EBURNAME DERIVATIVES
SE422052B (en) PROCEDURE FOR PREPARING CERTAIN STATED 1-PHENOXY-2-HYDROXY-3-AMINOPHENYL PROPYL DERIVATIVES
SE7606538L (en) PROCEDURE FOR PREPARING A MONSTER-PERFORMED SKI AS WELL AS A SUITABLE-LAYED SKI
SE7601125L (en) PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT
NO147672C (en) ANALOGUE PROCEDURE FOR PREPARING N-ARYL-N- (1-L1-4-PIPERIDINYL) -ARYLACETAMIDES
SE440907B (en) PROCEDURE FOR PREPARING IMIDAZOLD DERIVATIVES WITH PHARMACEUTICAL EFFECT
SE437026B (en) PROCEDURE FOR PREPARING BENZOPYRANE DERIVATIVES WITH ANTIALLERGIC EFFECT
SE7801664L (en) PROCEDURE FOR PREPARING A COMPOSITION WITH AN ANESTHETIC EFFECT
MX3904E (en) PROCEDURE FOR PREPARING HETERO CYCLIC COMPOUNDS
SE7705851L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION
SE7512292L (en) PROCEDURE FOR PREPARING NAFTALEN ASSOCIATIONS WITH THERAPEUTIC EFFECT
SE405805B (en) PROCEDURE FOR PREPARING A SECRETARY PREPARATION WITH PROTRAHED EFFECT
SE7605751L (en) PROCEDURE FOR PREPARING A BENSOTIAZINE COMPOUND

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7600284-9

Effective date: 19891201

Format of ref document f/p: F